Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 06:45 (653 d 06:44 ago) – Posting: # 20125
Views: 2,531

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 10 (0 registered, 10 guests [including 6 identified bots]).
Forum time: Sunday 13:30 UTC (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5